ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $230,868 | +13.2% | 5,692 | -3.1% | 0.13% | +10.5% |
Q2 2022 | $204,000 | -24.4% | 5,872 | 0.0% | 0.11% | -7.3% |
Q1 2022 | $270,000 | -30.6% | 5,872 | 0.0% | 0.12% | -19.1% |
Q4 2021 | $389,000 | -10.8% | 5,872 | -15.9% | 0.15% | -15.6% |
Q3 2021 | $436,000 | -25.1% | 6,984 | -0.6% | 0.18% | -27.4% |
Q2 2021 | $582,000 | +17.3% | 7,024 | -4.7% | 0.25% | +17.0% |
Q1 2021 | $496,000 | -11.9% | 7,373 | 0.0% | 0.21% | -20.0% |
Q4 2020 | $563,000 | +77.6% | 7,373 | 0.0% | 0.26% | +43.2% |
Q3 2020 | $317,000 | +0.6% | 7,373 | +1.0% | 0.18% | -3.6% |
Q2 2020 | $315,000 | +50.0% | 7,303 | -2.4% | 0.19% | +11.6% |
Q1 2020 | $210,000 | – | 7,482 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |